News

As the U.S. introduces sweeping tariff reforms and redefines global trade dynamics, Aldous Mitchell, Partner at Candesic, highlights how these shifts are reshaping strategies for life sciences firms across the U.S. and Europe in the May edition of LaingBuisson’s HealthcareMarkets.The U.S. ...

Read more

Dr Leonid Shapiro, Managing Partner at Candesic, shares insights with Healthcare Business International on Fremman Capital’s acquisition of Amethyst Healthcare Group and what it signals for Europe’s radiotherapy sector.He highlights growing consolidation in a fragmented market and how new ...

Read more

As the number and complexity of clinical trials rises, participants are an increasingly precious resource.In an online piece for PharmaTimes, Candesic Managing Partner Dr Leonid Shapiro, Principal Floris Wentholt, and Senior Adviser Dr Joe Taylor look for an answer, and find it, in part, in ...

Read more

NICE (National Institute for Health and Care Excellence) has set out its proposals for moving towards a more integrated, rules-based and predictable pathway for the evaluation, funding and commissioning of medtech in the NHS. You can see the consultation document here: ...

Read more

The latest interview in our regular "Candesic in conversation with" series sees us chatting with Tim Clover, CEO of UK-based ophthalmology medical product specialist Rayner. In a wide-ranging exclusive chat, he shares his candid thoughts on the state of the market, new tech developments, ...

Read more

As fans of numerous science fiction series know (Matrix, Terminator, et al. we are looking at you), before too long our future robot overloads may be plotting our demise. In the meantime, however, they are proving to be incredibly helpful in areas like pharma manufacturing, attracting billions ...

Read more

Dr Michelle Tempest, Senior Partner at Candesic, is the co-author of "The Brain Economy: Advancing Brain Science to Better Understand the Modern Economy" report launched at the World Economic Forum.

Read more

What is in store for healthtech investment in 2024? Candesic Senior Partner Dr Michelle Tempest shares her views with HealthInvestor. Beyond the expectation of further growth, key trends are expected to include: continued investment appetite from established corporates for both speculative ...

Read more

We are thrilled to announce Candesic Senior Partner Dr Michelle Tempest, continues to drive the exciting brain capital initiative with the Rice University's Baker Institute for Public Policy. The new paper "7 Steps for Igniting the Brain Capital Industrial Strategy" advocates for building ...

Read more

Marc Kitten, Senior Partner at Candesic shares his expertise on Employee Assistance Programmes (EAP) which over the years have evolved to become an all-encompassing employee wellbeing offering. Continued expansion of digital wellbeing offerings and the increased awareness of mental health, have ...

Read more